Amongst the myriad of inflammatory cytokines and chemokines released in asthma and COPD, several have also been identified in
Abcg1-knockout mice. Levels of the inflammatory cytokines tumour necrosis factor (TNF)-α and IL-1β were markedly elevated in lungs of
Abcg1-deficient chow-fed mice [
19]. TNF-α is expressed in multiple lung cell types, including macrophages, lymphocytes, mast cells and ASM cells, and promotes oxidative damage that subsequently activates NF-κB and AP-1. Results of this activation include recruitment of adhesion molecules, lymphocytes, and other inflammatory cytokines, and increased airway hyperresponsiveness [
50]. IL-1β has been shown to cause inflammation, airway fibrosis, bronchiolar thickening and mucus metaplasia – features that are prominent in COPD and asthma. Furthermore, IL-1β enhanced production of matrix metalloproteinases (MMP)-9 and −12 in neutrophils and macrophages of murine airways respectively [
51]. MMPs that degrade extracellular matrix are overexpressed in patients with COPD and asthma, and have been associated with airway inflammation and remodelling [
52]. Elevated levels of MMP-8 and MMP-12 have also been reported in lungs of
Abcg1
−/−
mice [
19]. Alveolar macrophages also play a pivotal role in orchestrating the inflammatory processes in COPD and asthma by secreting numerous pro-inflammatory cytokines and chemokines [
3]. However, they also secrete inhibitory mediators such as IL-10 that dampen inflammation, but this secretion is thought to be impaired in patients with asthma [
53]. These activities were reflected in the alveolar macrophages of
Abcg1
−/−
mice, with Wojtik and coauthors reporting significantly elevated pro-inflammatory IL-1, IL-6 and IL-12 levels, and decreased expression of the anti-inflammatory cytokine IL-10 [
48]. Another study indicated that following an asthma allergen challenge in
Abcg1
−/−
mice, airway neutrophil and IL-17 levels were elevated compared to wild-type [
46]. Although it was not specified which IL-17 subtype was elevated, a separate study showed that IL-17A contributes to glucocorticoid-insensitivity by decreasing the activity of histone deacetylase-2, an enzyme that normally mediates the anti-inflammatory effects of glucocorticoids [
54]. Taken together, evidence from
Abcg1
−/−
mouse models suggest that disruption to ABCG1 activity results in a phenotype reflective of inflammatory lung disease.